0.04Open0.04Pre Close0 Volume2 Open Interest36.00Strike Price0.00Turnover176.99%IV44.97%PremiumNov 22, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type0.0251Delta0.0131Gamma621.50Leverage Ratio-0.0270Theta0.0001Rho15.57Eff Leverage0.0015Vega
Pfizer Stock Discussion
bottom or not?
more selling
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
No comment yet